These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8808694)

  • 1. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R; Dudek H; Patel G; Reddy EP
    Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-myb alters the response of myeloid precursor cells to G-CSF.
    Engelhard A; Campbell K; Calabretta B
    Exp Cell Res; 2000 Jan; 254(1):153-62. PubMed ID: 10623475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
    Bies J; Mukhopadhyaya R; Pierce J; Wolff L
    Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
    Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
    Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
    Dudek H; Reddy EP
    Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype.
    Krüger A; Anderson SM
    Oncogene; 1991 Feb; 6(2):245-56. PubMed ID: 1705687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).
    Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G
    Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages.
    Fu SL; Lipsick JS
    Cell Growth Differ; 1997 Jan; 8(1):35-45. PubMed ID: 8993832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
    Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
    Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation by human c-myb and v-myb genes.
    Kalkbrenner F; Guehmann S; Moelling K
    Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH; Gorse KM; Westin EH
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
    Lyon JJ; Watson RJ
    Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.